Wayfinding Financial’s Insmed INSM Stock Holding History

Wayfinding Financial’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-223	Closed	-$17K	–	425
2025 Q1	$17K	Buy	+223	New	+$17.1K	0.01%	596

Other funds holding INSM

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wayfinding Financial's INSM Position: Q2 2025 in Review

Wayfinding Financial sold out of Insmed (INSM) in Q2 2025, closing a stake of 223 shares — an estimated $17K sold.

Wayfinding Financial first reported a position in INSM in Q1 2025 and held it in 1 quarter. The position peaked at $17K in Q1 2025. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

Wayfinding Financial reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
Wayfinding Financial sold 223 Insmed shares in Q2 2025, an estimated $17K.
Wayfinding Financial first reported a position in Insmed in Q1 2025 and held it in 1 quarter.
Wayfinding Financial's Insmed position peaked at $17K in Q1 2025.
516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Wayfinding Financial's 13F filing for Q2 2025, filed 12 Aug 2025.